Signal Transduct Target Ther January 2023 PMID 36604431

Neoantigens: promising targets for cancer therapy.

Na Xie, Guobo Shen, Wei Gao, Zhao Huang, Canhua Huang, Li Fu

Full text PDF Download social card

Mentions

Peak: 4 in Jan 2023

across 4 sources since Jan 2023

Extended reach

24,079

potential audience

Total likes

Video views

Mentions per month

Jan 2023 – May 2025

Where it's discussed

News15 articles
X / Twitter6 posts
Blogs3 articles
YouTube1 videos

AI synopsis

What people are saying

The digital discussions reflect a positive reception, with phrases like 'promising targets' and sharing links to the publication, indicating interest and support for neoantigens as cancer therapy targets. The tone is generally optimistic, emphasizing their potential rather than critiquing or deeply analyzing technical details, which aligns with moderate engagement and perceived impact.

AgreementModerate agreement

Most discussions express support or acknowledgment of the article’s importance, indicating general agreement with its potential impact.

InterestHigh interest

The discussions focus on the promising aspects of neoantigens and their relevance in cancer therapy, showing high interest.

EngagementModerate engagement

Posts mostly share brief endorsements or direct references to the publication, indicating moderate depth of engagement.

ImpactModerate impact

Though the discussions recognize the therapeutic potential, they mainly highlight the article's promising future rather than immediate breakthroughs.

Abstract in brief

Neoantigens are new tumor-specific antigens generated by genetic mutations and other alterations in cancer cells, which trigger immune responses because the body recognizes them as foreign.
Advances in sequencing and bioinformatics have made it easier to quickly identify these neoantigens, making them promising targets for personalized cancer immunotherapies like vaccines, cell therapy, and antibody treatments, especially for solid tumors.
Understanding how neoantigens stimulate immune responses and overcoming current challenges could enhance cancer treatment efficacy, with ongoing research focusing on their clinical applications and potential for improving prognosis and therapy responses.]

Read the full abstract

All mentions

Neoantigens as Targets for Personalized Cancer Immunotherapy

Neoantigens are tumor-specific antigens caused by genetic mutations, triggering immune responses. Advances in sequencing enable their identification, making them promising targets for personalized cancer treatments like…

Medicine RTCL TV · Apr 26, 2023 36 views

Tanyc

@Tanyc2015 · X

@TheRealTRTalks Neoantigens: promising targets for cancer therapy 2023 https://t.co/Mh0fTNVTW7

May 31, 2025 · 83 followers View post →

Stovetops

@CheshireScat528 · X

RT @mac_jamil: Neoantigens: promising targets for cancer therapy | Signal Transduction and Targeted Therapy https://t.co/dExMWHdOe7

Aug 9, 2023 · 1 share · 108 followers View post →

SWOG Cancer Research Network

@SWOG · X

Our #TranslationalMedicine link of the week, chosen by @SWOG's @recnac1 & Jimmy Rae, PhD: Neoantigens: Promising Targets for Cancer Therapy https://t.co/P1hAMd1FhU https://t.co/wp7yTFDxMk

Jan 13, 2023 · 1 like · 14,444 followers View post →

javier ospina

@javierospina20 · X

RT @AndresFCardonaZ: Neoantigens: promising targets for cancer therapy https://t.co/bwn6j5R4LC

Jan 9, 2023 · 1 share · 206 followers View post →

Andres F. Cardona

@AndresFCardonaZ · X

Neoantigens: promising targets for cancer therapy https://t.co/bwn6j5R4LC

Jan 8, 2023 · 8 likes · 1 share · 8,836 followers View post →

Mac Jamil

@mac_jamil · X

Neoantigens: promising targets for cancer therapy | Signal Transduction and Targeted Therapy https://t.co/dExMWHdOe7

Jan 6, 2023 · 1 share · 358 followers View post →